Literature DB >> 10762751

Familial predisposition to breast cancer in a British population: implications for prevention.

P D Pharoah1, J M Lipscombe, K L Redman, N E Day, D F Easton, B A Ponder.   

Abstract

The aims of this study were to estimate the familial relative risk of breast cancer according to the age of the at risk individual and the age at which the relative was affected, and to estimate the proportion of the general population in several breast cancer risk categories because of a family history and, thus estimate the potential to reduce the overall breast cancer burden using interventions targeted at women at increased risk because of family history. Familial relative risks were computed by comparing breast cancer incidence in relatives of 2809 breast cancer cases from a population based case series with that expected from general population incidence rates. The proportion of the general population in different categories of risk according to family history was estimated from the relative risk of breast cancer for that category and the proportion of cases in that category. 389 (13.8%) cases had at least 1 first degree relative with breast cancer. The relative risk of breast cancer in sisters of index cases was 1.90 (95% confidence interval (CI) 1.63-2.36) and that in mothers 1.73 (1.52-1. 97). The risk to mothers of cases diagnosed under 50 years of age tended to decrease in older mothers, but no age effect was seen for mothers of cases diagnosed >/=50 years of age. There was no evidence that relative risk to sisters declined with age. For women with 2 affected first degree relatives the relative risk was 2.85 (2.12-3. 76). From these data, we estimate that in the general population 6. 8% of women under the age of 50 years and 9.7% of women aged 50-65 years have at least 1 first degree relative affected with breast cancer. Two per cent of women under 50 years have a family history which confers an increased risk of at least 2.5-fold. An intervention targeted at this group that reduced breast cancer morbidity by 20% would reduce the total burden of breast cancer in this age group by 1.1% at most. A family history of breast cancer is quite common in the general population, but preventive interventions targeted at women at high risk of breast cancer because of family history will have limited impact on breast cancer morbidity as a whole.

Entities:  

Mesh:

Year:  2000        PMID: 10762751     DOI: 10.1016/s0959-8049(00)00023-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

Review 1.  Genetic susceptibility to breast cancer.

Authors:  Nasim Mavaddat; Antonis C Antoniou; Douglas F Easton; Montserrat Garcia-Closas
Journal:  Mol Oncol       Date:  2010-05-21       Impact factor: 6.603

2.  Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County.

Authors:  Sara Margolin; Hemming Johansson; Lars Erik Rutqvist; Annika Lindblom; Tommy Fornander
Journal:  Fam Cancer       Date:  2006-07-01       Impact factor: 2.375

3.  Predicting breast cancer risk: implications of a "weak" family history.

Authors:  Elaine Anderson; Jonathan Berg; Roger Black; Nicola Bradshaw; Joyce Campbell; Roseanne Cetnarskyj; Sarah Drummond; Rosemarie Davidson; Jacqueline Dunlop; Alison Fordyce; Barbara Gibbons; David Goudie; Helen Gregory; Kirstie Hanning; Susan Holloway; Mark Longmuir; Lorna McLeish; Vicky Murday; Zosia Miedzybrodska; Donna Nicholson; Pauline Pearson; Mary Porteous; Marta Reis; Sheila Slater; Karen Smith; Elizabeth Smyth; Lesley Snadden; Michael Steel; Diane Stirling; Cathy Watt; Catriona Whyte; Dorothy Young
Journal:  Fam Cancer       Date:  2008-06-17       Impact factor: 2.375

4.  Familial relative risks for breast cancer by pathological subtype: a population-based cohort study.

Authors:  Nasim Mavaddat; Paul D Pharoah; Fiona Blows; Kristy E Driver; Elena Provenzano; Deborah Thompson; Robert J Macinnis; Mitul Shah; Douglas F Easton; Antonis C Antoniou
Journal:  Breast Cancer Res       Date:  2010-02-10       Impact factor: 6.466

5.  DNA repair gene variants associated with benign breast disease in high cancer risk women.

Authors:  Timothy J Jorgensen; Kathy J Helzlsouer; Sandra C Clipp; Judy Hoffman Bolton; Rosa M Crum; Kala Visvanathan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

6.  Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.

Authors:  Ella R Thompson; Maria A Doyle; Georgina L Ryland; Simone M Rowley; David Y H Choong; Richard W Tothill; Heather Thorne; Daniel R Barnes; Jason Li; Jason Ellul; Gayle K Philip; Yoland C Antill; Paul A James; Alison H Trainer; Gillian Mitchell; Ian G Campbell
Journal:  PLoS Genet       Date:  2012-09-27       Impact factor: 5.917

7.  Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil.

Authors:  Edenir I Palmero; Maira Caleffi; Lavínia Schüler-Faccini; Fernanda L Roth; Luciane Kalakun; Cristina Brinkmann Oliveira Netto; Giovana Skonieski; Juliana Giacomazzi; Bernadete Weber; Roberto Giugliani; Suzi A Camey; Patricia Ashton-Prolla
Journal:  Genet Mol Biol       Date:  2009-09-01       Impact factor: 1.771

8.  Consensus recommendations for advancing breast cancer: risk identification and screening in ethnically diverse younger women.

Authors:  Alexander Stojadinovic; Thomas A Summers; John Eberhardt; Albert Cerussi; Warren Grundfest; Charles M Peterson; Michael Brazaitis; Elizabeth Krupinski; Harold Freeman
Journal:  J Cancer       Date:  2011-04-20       Impact factor: 4.207

9.  A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients.

Authors:  K E Bennett; A Howell; D G R Evans; J M Birch
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

10.  Family history and risk of breast cancer: an analysis accounting for family structure.

Authors:  Hannah R Brewer; Michael E Jones; Minouk J Schoemaker; Alan Ashworth; Anthony J Swerdlow
Journal:  Breast Cancer Res Treat       Date:  2017-06-03       Impact factor: 4.872

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.